Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH MEDIA
GLOBETECH PUBLISHING LLC

Membrane Chromatography Issues Addressed by New Smartphone Application

By BiotechDaily International staff writers
Posted on 31 Jul 2013
Image: Example of a Sartobind App screen (Photo courtesy of Sartorius Stedim Biotech).
Image: Example of a Sartobind App screen (Photo courtesy of Sartorius Stedim Biotech).
A new smartphone application will benefit biotech researchers and other life scientists who employ membrane chromatographic techniques, whether they are novices or expert practitioners.

Sartorius Stedim Biotech (Aubagne, France) recently introduced the Sartobind App to complement its Sartobind membrane adsorber portfolio. The application (app) was optimized for Apple iPhones but will run on many android smartphones as well.

The company will use the app to provide mobile phone users with a selection of training tools to complement its chromatography product portfolio and provide links to all the literature available in its digital library.

The app features a product finder that enables both novices and experts to select the appropriate membranes required for various chromatography processes and procedures. Beginning chromatographers will benefit from the app's Ion Exchange Calculator, which clarifies the interplay between pH and the isoelectric point of the protein of interest.

A flexible search function for downloading application notes and other literature according to search parameters related to target molecule, membrane type, device format, and scale will be appreciated by more experienced users. Other valuable features for all users are a flow rate calculator, an isoelectric point list for proteins and viruses, a comprehensive chromatography glossary, and a FAQ document.

The chromatography app can be downloaded free-of-charge online (please see Related Links below.

Related Links:
Sartorius Stedim Biotech
Chromatography app



Channels

Genomics/Proteomics

view channel
Image: Pluristem technicians produce PLacental eXpanded (PLX) cells in the company\'s state-of-the-art facility (Photo courtesy of Pluristem Therapeutics).

Placental Cells Secrete Factors That Protect Nerves from Ischemic Damage

Cells derived from placenta have been found to protect PC12 cells—rat-derived cells that behave similarly to and are used as stand-ins to study human nerve cells—in a culture-based ischemic stroke model.... Read more

Drug Discovery

view channel
Image: Researchers have attached two drugs—TRAIL and Dox—onto graphene strips. TRAIL is most effective when delivered to the external membrane of a cancer cell, while Dox is most effective when delivered to the nucleus, so the researchers designed the system to deliver the drugs sequentially, with each drug hitting a cancer cell where it will do the most damage (Photo courtesy of Dr. Zhen Gu, North Carolina State University).

Anticancer Drug Delivery System Utilizes Graphene Strip Transporters

The ongoing search by cancer researchers for targeted drug delivery systems has generated a novel approach that uses graphene strips to transport simultaneously the anticancer agents TRAIL (tumor necrosis... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Therapeutics

view channel
Image: Cancer cells infected with tumor-targeted oncolytic virus (red). Green indicates alpha-tubulin, a cell skeleton protein. Blue is DNA in the cancer cell nuclei (Photo courtesy of Dr. Rathi Gangeswaran, Bart’s Cancer Institute).

Innovative “Viro-Immunotherapy” Designed to Kill Breast Cancer Cells

A leading scientist has devised a new treatment that employs viruses to kill breast cancer cells. The research could lead to a promising “viro-immunotherapy” for patients with triple-negative breast cancer,... Read more

Business

view channel

Program Designed to Provide High-Performance Computing Cluster Systems for Bioinformatics Research

Dedicated Computing (Waukesha, WI, USA), a global technology company, reported that it will be participating in the Intel Cluster Ready program to deliver integrated high-performance computing cluster solutions to the life sciences market. Powered by Intel Xeon processors, Dedicated Computing is providing a range of... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.